| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/TP.0B013E3181933261 |
| P698 | PubMed publication ID | 19155973 |
| P2093 | author name string | Yu Zhang | |
| Lei Tian | |||
| Timothy D O'Brien | |||
| Bernhard J Hering | |||
| Huimin Yi | |||
| David E R Sutherland | |||
| Zhiguang Guo | |||
| Jianqiang Hao | |||
| Bole Tian | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymph node | Q170758 |
| immunotherapy | Q1427096 | ||
| P304 | page(s) | 198-206 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy | |
| P478 | volume | 87 |
| Q34140473 | Adjuvant Immunotherapy Increases β Cell Regenerative Factor Reg2 in the Pancreas of Diabetic Mice |
| Q37704840 | Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system |
| Q99711793 | Autoimmune thyroid disease and type 1 diabetes mellitus: same pathogenesis; new perspective? |
| Q37728130 | CD52 as both a marker and an effector molecule of T cells with regulatory action: Identification of novel regulatory T cells |
| Q34703152 | CXC chemokine ligand 10 DNA vaccination plus Complete Freund's Adjuvant reverses hyperglycemia in non-obese diabetic mice |
| Q44841302 | Comparison of exendin-4 on beta-cell replication in mouse and human islet grafts |
| Q37042082 | Factors affecting transplant outcomes in diabetic nude mice receiving human, porcine, and nonhuman primate islets: analysis of 335 transplantations |
| Q30039774 | Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells |
| Q39325157 | Identification and Characterization of microRNAs Associated With Human β-Cell Loss in a Mouse Model |
| Q35645163 | Immunological Basis for Rapid Progression of Diabetes in Older NOD Mouse Recipients Post BM-HSC Transplantation |
| Q44251400 | Immunomodulation therapy of diabetes by oral administration of a surfactin lipopeptide in NOD mice |
| Q33920298 | Implications of Lymphatic Transport to Lymph Nodes in Immunity and Immunotherapy |
| Q37540986 | Liraglutide Enhances the Efficacy of Human Mesenchymal Stem Cells in Preserving Islet β-cell Function in Severe Non-obese Diabetic Mice |
| Q90407131 | Long-Term Provision of Acidified Drinking Water Fails to Influence Autoimmune Diabetes and Encephalomyelitis |
| Q38966071 | Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes |
| Q37351448 | Persistent suppression of type 1 diabetes by a multicomponent vaccine containing a cholera toxin B subunit-autoantigen fusion protein and complete Freund's adjuvant |
| Q48159465 | Protective effects of carbonyl iron against multiple low-dose streptozotocin-induced diabetes in rodents. |
| Q34629092 | Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit. |
| Q38607412 | TNF, TNF Inducers and TNFR2 Agonists: A New Path to Type 1 Diabetes Treatment. |
| Q43280097 | Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis |
| Q33577441 | Targeting Janus tyrosine kinase 3 (JAK3) with an inhibitor induces secretion of TGF-β by CD4+ T cells |
| Q48055643 | Targeting innate immunity for treatment of type 1 diabetes |
| Q53357495 | Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice. |
| Q34983677 | Testing agents for prevention or reversal of type 1 diabetes in rodents |
| Q47695204 | The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment. |
| Q47611584 | The hygiene hypothesis in autoimmunity: the role of pathogens and commensals |
| Q37727850 | Treg cells in pancreatic lymph nodes: the possible role in diabetogenesis and β cell regeneration in a T1D model |
| Q27013927 | Use of glucagon-like peptide-1 agonists to improve islet graft performance |
| Q34355286 | Virtual optimization of nasal insulin therapy predicts immunization frequency to be crucial for diabetes protection |
Search more.